Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Insiders Buying Iterum Therapeutics And 3 Other Stocks Under $3

Author: Avi Kapoor | December 28, 2023 10:18am

The Dow Jones index closed higher by over 100 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Iterum Therapeutics

  • The Trade: Iterum Therapeutics plc (NASDAQ:ITRM) Director Michael W Dunne acquired a total of 25,000 shares an average price of $1.40. To acquire these shares, it cost around $35,000.
  • What’s Happening: Iterum Therapeutics recently regained compliance with Nasdaq Bid Price Rule for continued listing.
  • What Iterum Therapeutics Does: Iterum Therapeutics PLC is a clinical-stage pharmaceutical company. The company is engaged in developing and commercializing sulopenem to be the first and only oral and intravenous branded penem available globally.

Retractable Technologies

  • The Trade: Retractable Technologies, Inc. (NYSE:RVP) President and CEO Thomas J Shaw acquired a total of 7,706 shares at an average price of $1.10. To acquire these shares, it cost around $8,440.
  • What’s Happening: On Nov. 14, Retractable Technologies reported that its loss from operations was $8.7 million for the first nine months of 2023.
  • What Retractable Technologies Does: Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession.

Check This Out: How To Earn $500 A Month From Apple Stock

Collective Audience

  • The Trade: Collective Audience, Inc. (NASDAQ:CAUD) Director Denis Duncan acquired a total of 20,000 shares at an average price of $1.24. The insider spent around $24,800 to buy those shares.
  • What’s Happening: Collective Audience recently appointed Peter Bordes, as Chief Executive Officer.
  • What Collective Audience Does: Collective Audience Inc is a provider of e-commerce and digital customer acquisition solutions by simplifying digital advertising.

NetSol Technologies

  • The Trade: NetSol Technologies, Inc. (NASDAQ:NTWK) President Naeem Ghauri acquired a total of 6,172 shares at an average price of $2.08. The insider spent around 12,838 to buy those shares.
  • What’s Happening: NETSOL Technologies, last month, posted an increase in quarterly sales.
  • What NetSol Technologies Does: NETSOL Technologies Inc is involved in providing information technology and enterprise software solutions.

 

Don’t forget to check out our premarket coverage here

 

Posted In: CAUD ITRM NTWK RVP

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist